© 2025 Omaada - A global social and professionals networking platform
Deutsch

Neueste Updates
-
Guillain-Barre Syndrome Market Leading Players and Growth Forecast To 2031The global Guillain-Barre Syndrome (GBS) Market, valued at US$ 591.3 million in 2022, is projected to grow at a compound annual growth rate (CAGR) of 4.7% from 2023 to 2031, reaching US$ 890.2 million by 2031. GBS is a rare autoimmune neurological disorder where the immune system attacks peripheral nerves, causing muscle weakness and, in severe cases, paralysis. The market, encompassing...0 Kommentare 0 Geteilt 0 BewertungenBitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
-
Mesenchymal Stem Cells Market Size 2031 (New Research) Report Reveals the Latest Trends and Growth OpportunitiesThe global Mesenchymal Stem Cells (MSCs) Market, valued at US$ 3.2 billion in 2022, is projected to grow at a robust compound annual growth rate (CAGR) of 12.7% from 2023 to 2031, surpassing US$ 10.1 billion by 2031. MSCs, multipotent stem cells derived from bone marrow, adipose tissue, and umbilical cord, are used in regenerative medicine for conditions like osteoarthritis, cardiovascular...0 Kommentare 0 Geteilt 0 Bewertungen
-
Anticoagulant Reversal Drugs Market Growth Outlook, Opportunities and Forecast 2031The global Anticoagulant Reversal Drugs Market, valued at US$ 829.5 million in 2021, is projected to grow at a compound annual growth rate (CAGR) of 11.3% from 2022 to 2031, reaching more than US$ 2.3 billion by 2031. Anticoagulant reversal drugs, such as idarucizumab and andexanet alfa, are used to reverse the effects of anticoagulants in cases of life-threatening bleeding or emergency...0 Kommentare 0 Geteilt 0 Bewertungen
-
Generic Injectables Market Size, Share, Status and Industry Forecast 2031The global Generic Injectables Market is projected to surpass US$ 307.7 billion by 2031, expanding at a robust compound annual growth rate (CAGR) of 12.3% from 2021 to 2031. Generic injectables, bioequivalent alternatives to branded injectable drugs, are used in oncology, infectious diseases, and cardiovascular conditions, offering cost-effective treatment options. The market's growth is driven...0 Kommentare 0 Geteilt 0 Bewertungen
-
Porcine Vaccines Market Growth Research and Future Outlook 2025The global Porcine Vaccines Market, valued at US$ 1,784.0 million in 2016, is projected to grow at a compound annual growth rate (CAGR) of over 7.0% from 2017 to 2025, reaching US$ 3,208.8 million by 2025. Porcine vaccines protect swine from diseases like porcine epidemic diarrhea (PED), porcine reproductive and respiratory syndrome (PRRS), and swine influenza, enhancing meat quality and farm...0 Kommentare 0 Geteilt 0 Bewertungen
Mehr Storys